
HAND & WRIST
NeuFlex vs. Swanson metacarpophalangeal implants in treatment of RA
This report has been verified
by one or more authors of the
original publication.
J Hand Surg Am. 2010 Jan;35(1):44-51
33 patients (age range 39-80) presenting with rheumatoid arthritis affecting (40 hands) were randomized to be managed with metacarpophalangeal joint (MCP) replacement with either NeuFlex or Swanson MCP implants. Both implants resulted in clinically satisfactory improvement in patients with rheumatoid arthritis; however, the NeuFlex implant offered better range of motion and the Swanson implant was liked better by patients for self reported function and aesthetics.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in


Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now